CAJ | 학술논문

洛铂是第3代铂类抗肿瘤药物,已上市用于临床治疗晚期乳腺癌、小细胞肺癌和慢性粒细胞白血病.研究表明洛铂作为最新的第3代铂类抗肿瘤药物,具有水溶性好,抗瘤谱广、抗瘤活性强,与其他铂类药物无交叉耐药性及不良反应低诸多特点,已经显示出明显的优势.
락박시제3대박류항종류약물,이상시용우림상치료만기유선암、소세포폐암화만성립세포백혈병.연구표명락박작위최신적제3대박류항종류약물,구유수용성호,항류보엄、항류활성강,여기타박류약물무교차내약성급불량반응저제다특점,이경현시출명현적우세.
Lobaplatin is the third generation platinum anticancer drug,and has been listed for the clinical treatment of advanced breast cancer,small cell lung cancer and chronic myeloid leukemia.Studies have shown that lobaplatin as the latest third generation platinum anticancer drug,has good water solubility,broadspectrum anti-tumor,strong anti-tumor activity,no cross-resistance with other platinum drugs,low toxicity and many other features.Lobaplatin has shown a clear advantage.